Adaltis Inc. (Adaltis) is an in-vitro diagnostic company that develops, manufactures and markets in -vitro diagnostic systems. It offers diagnostic products, including automated diagnostic systems consisting of instruments, reagents and software, which test for a range of medical conditions. Its software assists in the interpretation of data collected from its instruments and reagents. Adaltis also provides services to its customers, such as installation, technical training and support. Its customers consist primarily of small and medium-sized laboratories and hospitals. Its sales force concentrates on the Chinese and Italian markets, while its third-party distribution network reaches customers in other countries worldwide. In August 2009, Adaltis announced that it has filed a voluntary assignment in bankruptcy under the Bankruptcy and Insolvency Act (Canada) in order to effect an orderly liquidation of its assets, property and operations.
Quick Financial Synopsis
BRIEF: For the three months ended 31 March 2009, Adaltis Inc.'s revenues increased 34 to C$6.7M. Net loss from continuing operations decreased 16% to C$6.4M. Revenues reflect an increase in the sales & rental income. Lower loss reflects a decrease in research & development expenses, lower stock based compensation expenses and the absence of loss on investment in asset-backed commercial paper. The Co. researchs innovative products for the of human disesase.
Company Address
Adaltis Inc.
10900 Hamon St Montreal QC H3M 3A2
P: +1514.3359922 F: +1514.3359919